A novel in vivo bioassay of topical drug potency and stability: An effective correlate to clinical SCORAD in atopic dermatitis - 21/04/16
Philip Alex, MD, PhD, Haus Bioceuticals, Oklahoma City, OK, United States; Sarah Williams, Haus Bioceuticals, Oklahoma City, OK, United States; Liz Sutton, Haus Bioceuticals, Oklahoma City, OK, United States; Chris Sutton, PhD, Haus Bioceuticals, Oklahoma City, OK, United States; Adam Payne, MBA, Haus Bioceuticals, Oklahoma City, OK, United States; Michael Centola, PhD, Haus Bioceuticals, Oklahoma City, OK, United States
Le texte complet de cet article est disponible en PDF. Supported by Haus Bioceuticals |
Vol 74 - N° 5S1
P. AB83 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?